Qiagen N.V. (QIA.DE) stock analysis

In our weekly check, Qiagen N.V. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 6, red flags: 2.

About Qiagen N.V.

Qiagen N.V. is a Healthcare company (Medical - Diagnostics & Research) based in the Netherlands, listed on XETRA as QIA.DE.

What our checks show for QIA.DE

Red flags

Warning signs

Strengths

Next earnings report: 2026-11-04

Similar companies

ICLR · CRL · RVTY · GRAL · MEDP · RDNT

Questions

What grade does Qiagen N.V. (QIA.DE) have?

In our weekly check, Qiagen N.V. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 6, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of QIA.DE stock?

This week's biggest flags for Qiagen N.V.: Gross margin falling, Weak revenue growth, Margins falling. In total 8 of 25 checks show a warning or a red flag.

What does Qiagen N.V. do?

Qiagen N.V. is a Healthcare company (Medical - Diagnostics & Research) based in the Netherlands, listed on XETRA as QIA.DE.

When does Qiagen N.V. report earnings next?

The next earnings report is expected on 2026-11-04. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis